We are monitoring the impact of COVID-19 on MEA Insulin Delivery Devices Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 231
Share on
Share on

Middle East & Africa Insulin Delivery Devices Market Analysis Report - By Type, Application, Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Analysis on Size, Share, Trends, Growth, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 231
Pages: 145

MEA Insulin Delivery Devices Market Size (2021 to 2026)

As per the latest research report, the size of the insulin delivery devices market in the Middle East & Africa region is estimated to be worth USD 2.16 billion by 2026 from USD 1.43 billion in 2021, projecting a CAGR of 8.55% from 2021 to 2026.

Insulin maintains sugar levels in the blood and is essential for people who have type I diabetes & type II diabetes in the Middle East and Africa. Therefore, the development of insulin delivery devices has been encouraged in the past years. These devices are used to deliver insulin doses via the parenteral route rather than the oral route of administration. Insulin delivery devices promote the absorption rate of insulin into the bloodstream from injection to execute immediate pharmacological action of insulin. Some of the majorly used insulin delivery devices include insulin syringes, insulin pens, insulin pen needles, insulin pumps, and insulin jet injectors.

The growing aging population, increasing the incidence rate of diabetes among the population, rising government initiatives towards diabetes, and growing awareness among diabetes patients are factors driving the growth of the insulin delivery devices market in the Middle East and Africa.

However, insufficient healthcare infrastructure to maintain the advanced insulin delivery devices, inadequate number of physicians, and unavailability of social and economic facilities are expected to restrain the growth of the insulin delivery devices market in the Middle East and Africa.

This research report on the MEA Insulin Delivery Devices Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Insulin Syringes
  • Insulin Pens
  • Insulin Pen Needles
  • Insulin Pumps
  • Insulin Jet Injectors

By Application: 

  • Type I Diabetes
  • Type II Diabetes

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The MEA Insulin Delivery Devices market is expected to record a considerable share in the global market during the forecast period. Over the recent years, the prevalence of diabetes in people in the Middle East and Africa area has increased dramatically. It is the rise in the prevalence of cardiovascular diseases and obesity that are driving the market growth. However, the growing diabetes population is driving the demand for insulin delivery devices. Presently diabetes had affected over 5.42 million individuals in Saudi Arabia.

South Africa held the largest share of the insulin delivery devices market. The presence of the diabetic population significantly contributing to the insulin market growth. The prevalence of diabetes in South Africa is over 9 percent, with rising in the other problems obesity, healthcare expenditure. Moreover, the growing diabetes population drives the demand for insulin delivery devices.

Furthermore, the counties such as UAE and Saudi Arabia are projected to witness considerable share and contribute to the MEA regional market growth. The market growth is attributed to the growing need for insulin has prompted extensive R&D efforts to develop painless insulin delivery systems, such as CGM-integrated insulin pumps. Earlier syringes were the only way to administer insulin at first, and they were unpleasant and inconvenient to use. Therefore, this feature a fixed dosage form and is less uncomfortable to use; it will also help minimize insulin waste.

KEY MARKET PLAYERS:

Companies like Becton, Dickinson, and Company (U.S.), Sanofi (France), Novo Nordisk A/S (Denmark), Julphar (U.A.E.), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Ypsomed AG (Switzerland), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland) and Biodel Inc. (U.S.) are playing a promising role in the MEA Insulin Delivery Devices Market.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Introduction                                                               

                5.2 Type                                                              

                                5.2.1 Introduction                                           

                                5.2.2 Insulin Syringes                                     

                                5.2.3 Insulin Pens                                            

                                5.2.4 Insulin Pen Needles                                            

                                5.2.5 Insulin Pumps                                        

                                5.2.6 Insulin Jet Injectors                                             

                5.3 Application                                                 

                                5.3.1 Introduction                                           

                                5.3.2 Type I Diabetes                                     

                                5.3.3 Type II Diabetes                                    

6. Geographical Analysis                                                                              

                6.5.1 Introduction                                                           

                6.5.2 Middle East                                                             

                6.5.2 South Africa                                                            

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Sanofi (France)                                                         

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Novo Nordisk A/S (Denmark)                                                             

                8.3 Eli Lilly and Company (U.S.)                                                  

                8.4 Biocon Ltd. (India)                                                   

                8.5 Julphar (U.A.E.)                                                        

                8.6 Ypsomed AG (Switzerland)                                                  

                8.7 Becton, Dickinson and Company (U.S.)                                                          

                8.8 Wockhardt Ltd. (India)                                                           

                8.9 B. Braun Meselgen AG (Switzerland)                                                              

                8.10 Biodel Inc. (U.S.)                                                    

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Middle East & Africa Insulin Delivery Devices Market, By Region, From 2021 to 2026 (USD Million)
  2. Middle East & Africa Insulin Delivery Devices Market, By Type, From 2021 to 2026 (USD Million)
  3. Middle East & Africa Insulin Syringes Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East & Africa Insulin Pens Market, By Region, From 2021 to 2026 (USD Million)
  5. Middle East & Africa Insulin Pen Needles Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East & Africa Insulin Pumps Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East & Africa Insulin Jet Injectors Market, By Region, From 2021 to 2026 (USD Million)
  8. Middle East & Africa Insulin Delivery Devices Market, By Application, From 2021 to 2026 (USD Million)
  9. Middle East & Africa Type I Diabetes of Insulin Delivery Devices Market, By Region, From 2021 to 2026 (USD Million)
  10. Middle East & Africa Type II Diabetes of Insulin Delivery Devices Market, By Region, From 2021 to 2026 (USD Million)
  11. Middle East Insulin Delivery Devices Market, By Type, From 2021 to 2026 (USD Million)
  12. Middle East Insulin Delivery Devices Market, By Application, From 2021 to 2026 (USD Million)
  13. South Africa Insulin Delivery Devices Market, By Type, From 2021 to 2026 (USD Million)
  14. South Africa Insulin Delivery Devices Market, By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample